DCAF6 reprograms TGF-β responses through TRIM33 destruction
Open Access
- 28 October 2026
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (44)
Abstract
TGF-β signaling plays a pivotal role in regulating numerous cellular processes, primarily through the Smad-dependent pathway. Disruptions of the pathway are associated with developmental disorders and life-threatening diseases, such as cancer. It has been reported that TRIM33 inactivates Smad4 signaling and also drives its own signaling responses. However, the mechanism controlling TRIM33 activity has remained unclear. In this study, we identify DCAF6 as a previously unrecognized ubiquitin ligase for TRIM33. DCAF6 targets TRIM33 at Lys850 for ubiquitin-dependent proteasomal degradation, thus abolishing TRIM33-mediated mono-ubiquitination of Smad4. As such, DCAF6 induces dual consequences: it enhances Smad4-dependent transcriptional and growth inhibitory responses, while simultaneously eliminating TRIM33-dependent developmental responses. Conversely, DCAF6 knockout suppresses Smad4-dependent responses while amplifying TRIM33-dependent responses. Therefore, DCAF6 operates as a critical regulator in the balance of TGF-β signaling between the Smad4 and TRIM33 pathways. These insights deepen our understanding of the dynamics and fate control of TGF-β signaling and may open avenues for therapeutic approaches targeting TGF-β in diseases.Keywords
Funding Information
- National Natural Science Foundation of China (W2531062)
- National Natural Science Foundation of China (32321002)
- National Key Research and Development Program of China (2022YFC3401500)
- Natural Science Foundation of Zhejiang Province (LD21C070001)
- Fundamental Research Funds for the Central Universities (226-2024-00055)
This publication has 49 references indexed in Scilit:
- The CRL4DCAF6 E3 ligase ubiquitinates CtBP1/2 to induce apoptotic signalling and promote intervertebral disc degenerationJournal of Molecular Medicine, 2023
- Switching DCAFs: Beyond substrate receptorsBioEssays, 2021
- TGF-β signaling in cell fate control and cancerCurrent Opinion in Cell Biology, 2019
- TRIM33 is essential for osteoblast proliferation and differentiation via BMP pathwayJournal of Cellular Physiology, 2017
- Ovoid Palatal Patch in DermatomyositisJAMA Dermatology, 2016
- TIF1γ Controls Erythroid Cell Fate by Regulating Transcription ElongationCell, 2010
- FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 MonoubiquitinationCell, 2009
- TGFβ in CancerCell, 2008
- Hematopoiesis Controlled by Distinct TIF1γ and Smad4 Branches of the TGFβ PathwayCell, 2006
- Germ-Layer Specification and Control of Cell Growth by Ectodermin, a Smad4 Ubiquitin LigaseCell, 2005